Recorded Chinese product: 注射用肝水解肽注射用肝水解肽
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 湖南五洲通药业有限责任公司Chinese legal name: 湖南五洲通药业有限责任公司
主要成分Active Ingredients
- 核酸类Hesuan Lei
- 氨基酸类物质的无菌冻干粉Anji Suanlei Wuzhi Diwu Jundong Ganfen
药物知识说明
核酸类是一种在国家药监局注册认定的药品。标注生产企业为湖南五洲通药业有限责任公司。
该药品暂无关联的活性成分信息。
该药品标注的生产企业为：湖南五洲通药业有限责任公司Chinese legal name: 湖南五洲通药业有限责任公司、湖南五洲通药业有限责任公司Chinese legal name: 湖南五洲通药业有限责任公司、湖南五洲通药业有限责任公司Chinese legal name: 湖南五洲通药业有限责任公司。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 注射用肝水解肽) is a medicine registered with the national drug regulatory authority. It is manufactured by Chinese legal name: 湖南五洲通药业有限责任公司.
No active ingredient relationships are currently recorded for this product in MedicineGraph.
Manufacturers recorded for this product: 湖南五洲通药业有限责任公司Chinese legal name: 湖南五洲通药业有限责任公司, 湖南五洲通药业有限责任公司Chinese legal name: 湖南五洲通药业有限责任公司, 湖南五洲通药业有限责任公司Chinese legal name: 湖南五洲通药业有限责任公司.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 注射用肝水解肽Recorded Chinese product: 注射用肝水解肽
- 剂型Dosage form: 注射剂Injection
- 规格Specification: 50mg。50 mg
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
生产企业Manufacturer
- 湖南五洲通药业有限责任公司Chinese legal name: 湖南五洲通药业有限责任公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H20051098
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H20051098
Manufacturer
Chinese legal name: 湖南五洲通药业有限责任公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H20051098
生产企业
湖南五洲通药业有限责任公司(国产)
适应症
用于慢性肝炎、肝硬化等疾病的辅助治疗。
用法用量
肌内注射。一次20mg―40mg．用注射用水2ml溶解后注射，一日1次。
静脉滴注。一次1OOmg（2支），一日1次，用5%或10%葡萄糖注射液500ml溶解后缓慢滴注。
不良反应
尚不明确。
禁忌
对本品过敏者禁用。肝昏迷、严重氮质血症及氨基酸代谢障碍者禁用。
注意事项
1、本品为生物制剂，长时间高温，能使本品变浊或沉淀，应立即停止使用。
2、当药品性状发生改变时禁止使用。
3、家兔动物实验显示本品有轻度肌肉刺激性。
贮藏
密闭，在凉暗（遮光并不超过20℃）处保存。
规格
50mg。
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.